MediFind

Find a Doctor

Yan M. Kang

Sichuan University
Male

Bio


Yan Kang is in Chengdu, China. They have been an author on 187 peer reviewed articles and participated in 1 clinical trials in the past 15 years. Dr. Kang's top three areas of expertise are West Syndrome, Sepsis, and Acute Respiratory Distress Syndrome.

Contact

Chengdu, 61004, CN

Latest Research


Latest Advance
Study
  • Condition: Septic Shock
  • Journal: Intensive care medicine
  • Treatment Used: Terlipressin versus Norepinephrine
  • Number of Patients: 617
  • Published —
The study researched the use of Terlipressin versus Norepinephrine for patients with septic shock.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: IEEE transactions on ultrasonics, ferroelectrics, and frequency control
  • Published —
Application of Critical Care Ultrasound in patients with COVID-19: Our experience and perspective.
Publication
Study
  • Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
  • Published —
Association of Glucose Variability and ICU Delirium of Patients after Liver Transplantation

Contact

Chengdu, 61004, CN

Insurance

Contact them to find out if they accept your insurance plan.